Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines-Reference-Cited by-同舟云学术

Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines

Published:2020-12 Issue: Volume:9 Page:100162
ISSN:2666-3546
Container-title:Brain, Behavior, & Immunity - Health
language:en
Short-container-title:Brain, Behavior, & Immunity - Health

Author:

Tauil Carlos B.,da Rocha Lima Amanda D.,Ferrari Breno B.,da Silva Verônica A.G.,Moraes Adriel S.,da Silva Flávia M.,Melo-Silva César A.,Farias Alessandro S.,Brandão Carlos O.,Leonilda M.B. dosSantos,dos Santos-Neto Leopoldo L.

Funder

São Paulo Research Foundation

Distrito Federal Research Foundation

Publisher

Elsevier BV

Subject

General Medicine

Reference46 articles.

1. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells;Alberati-Giani;J. Neurochem.,1996

2. Autocrine and paracrine roles of sphingosine-1-phosphate;Alvarez;Trends Endocrinol. Metabol.,2007

3. Epidemiology of multiple sclerosis: from risk factors to prevention-an update;Ascherio;Semin Neurol. Apr,2016

4. Immunomodulatory effects mediated by serotonin;Arreola;J. Immunol. Res.,2015

5. An inventory for measuring depression;Beck;Arch. Gen. Psychiatr.,1961

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K/Akt/CREB/BDNF cascade and modulation of serotonergic pathway signaling;European Journal of Pharmacology;2024-11

2. Hesperidin Plays Neuroprotective Effects Against Quinolinic Acid in Human SH-SY5Y Cells: Focusing on ROS Levels and Cell Cycle Arrest;RES J PHARMACOGN;2024

3. Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions;Molecular Pain;2024-01

4. Therapeutic potential of thymoquinone and its nanoformulations in neuropsychological disorders: a comprehensive review on molecular mechanisms in preclinical studies;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-27

5. Modulation of salivary ICAM-1 and SIRT1 by disease modifying drugs in undepressed relapsing-remitting multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2022-12